Pekin Hardy Strauss Inc. Cuts Position in Oracle Corporation $ORCL

Pekin Hardy Strauss Inc. lessened its position in Oracle Corporation (NYSE:ORCLFree Report) by 38.0% during the second quarter, Holdings Channel reports. The fund owned 1,145 shares of the enterprise software provider’s stock after selling 701 shares during the period. Pekin Hardy Strauss Inc.’s holdings in Oracle were worth $250,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Nuveen LLC purchased a new stake in Oracle in the first quarter worth approximately $732,692,000. Vanguard Group Inc. lifted its holdings in shares of Oracle by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider’s stock worth $22,498,982,000 after acquiring an additional 3,513,464 shares during the last quarter. Kingstone Capital Partners Texas LLC purchased a new stake in shares of Oracle in the 2nd quarter valued at $731,512,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Oracle by 79.2% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,638,951 shares of the enterprise software provider’s stock valued at $648,572,000 after purchasing an additional 2,049,687 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its holdings in shares of Oracle by 840.7% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,119,473 shares of the enterprise software provider’s stock valued at $463,380,000 after purchasing an additional 1,894,157 shares during the last quarter. Institutional investors own 42.44% of the company’s stock.

Oracle Price Performance

ORCL opened at $239.15 on Friday. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.62 and a current ratio of 0.62. Oracle Corporation has a 52-week low of $118.86 and a 52-week high of $345.72. The stock has a market capitalization of $681.77 billion, a PE ratio of 55.36, a price-to-earnings-growth ratio of 2.96 and a beta of 1.51. The stock’s 50 day moving average price is $279.32 and its 200-day moving average price is $230.60.

Oracle (NYSE:ORCLGet Free Report) last announced its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). The business had revenue of $14.93 billion during the quarter, compared to analysts’ expectations of $15.04 billion. Oracle had a return on equity of 72.93% and a net margin of 21.08%.The business’s revenue was up 12.2% compared to the same quarter last year. During the same period in the previous year, the business earned $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, equities research analysts predict that Oracle Corporation will post 5 EPS for the current year.

Oracle Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, October 23rd. Investors of record on Thursday, October 9th were given a dividend of $0.50 per share. The ex-dividend date was Thursday, October 9th. This represents a $2.00 annualized dividend and a dividend yield of 0.8%. Oracle’s payout ratio is currently 46.30%.

Analysts Set New Price Targets

Several analysts have issued reports on ORCL shares. JMP Securities restated a “market outperform” rating and set a $342.00 price target on shares of Oracle in a research report on Friday, October 17th. Stephens boosted their target price on Oracle from $208.00 to $331.00 and gave the company an “equal weight” rating in a research note on Friday, October 17th. Mizuho raised their price target on Oracle from $300.00 to $350.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 10th. Citigroup reaffirmed a “buy” rating on shares of Oracle in a research note on Friday, October 10th. Finally, Evercore ISI increased their price objective on Oracle from $350.00 to $385.00 and gave the company an “outperform” rating in a research note on Friday, October 17th. Three research analysts have rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $323.69.

Check Out Our Latest Stock Analysis on ORCL

Insider Activity at Oracle

In other Oracle news, Director Jeffrey Berg sold 49,365 shares of the firm’s stock in a transaction dated Tuesday, October 28th. The shares were sold at an average price of $283.02, for a total value of $13,971,282.30. Following the completion of the sale, the director directly owned 151,999 shares in the company, valued at $43,018,756.98. This trade represents a 24.52% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Clayton M. Magouyrk sold 40,000 shares of Oracle stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of $276.64, for a total value of $11,065,600.00. Following the sale, the chief executive officer directly owned 154,030 shares in the company, valued at approximately $42,610,859.20. The trade was a 20.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 204,254 shares of company stock valued at $60,227,807 over the last three months. Corporate insiders own 40.90% of the company’s stock.

Oracle Profile

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Read More

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCLFree Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.